The following government grants in the FederalGrants.com database contain the term housing in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| FY 2020 AmeriCorps Tribes Grants |
94.006 |
CNCS-03-06-20 |
| Advancing Vaccine Science to Improve Tuberculosis Treatment Outcomes for People Living With or Without HIV (R01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-20-010 |
| Research Towards Developing a Cure for HBV in HIV/HBV Co-Infection (R21 Clinical Trial Not Allowed) |
93.855 |
PAS-20-121 |
| Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional) |
93.173 |
PAR-20-127 |
| Harnessing Natural Killer (NK) Cells to Prevent, Control, or Eradicate HIV (R01 Clinical Trial Not Allowed) |
93.242, 93.855 |
RFA-AI-20-016 |
| NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed) |
93.846 |
RFA-AR-21-003 |
| Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional) |
93.173 |
PAR-20-123 |
| NICHD Biomedical Informatic Resource Centers Grants (P41 Clinical Trial Not Allowed) |
93.865 |
PAR-20-126 |
| Regional Food System Partnerships |
10.177 |
USDA-AMS-TM-RFSP-G-20-0009 |
| NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens (U01) Clinical Trials Not Allowed |
93.876 |
PAR-20-124 |
| Research Education Program Grants for CryoEM and CryoET Curriculum Development (R25 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-20-010 |
| Exploring the Mechanisms Underlying Modulation of Glymphatic-Lymphatic Systems by Complementary and Integrative Health Approaches (R21 Clinical Trial Optional) |
93.121, 93.213 |
RFA-AT-21-002 |
| Local Food Promotion Program |
10.175 |
USDA-AMS-TM-LFPP-G-20-0001 |
| Farmers Market Promotion Program |
10.175 |
USDA-AMS-TM-FMPP-G-20-0002 |
| Exploring the Mechanisms Underlying Modulation of Glymphatic-Lymphatic Systems by Complementary and Integrative Health Approaches (R01 Clinical Trial Optional) |
93.121, 93.213 |
RFA-AT-21-001 |
| Rural Community Development Initiative |
10.446 |
USDA-RD-HCFP-RCDI-2020 |
| Urological Epidemiology (UroEpi) Institutional Research Career Development Program (K12 - Independent Clinical Trial Not Allowed) |
93.847 |
RFA-DK-20-001 |
| Integrated Preclinical / Clinical AIDS Vaccine Development Program (IPCAVD) (U19 Clinical Trial Not Allowed) |
93.855 |
PAR-20-120 |
| Strengthening the Impact of Community Health Workers on the HIV Care Continuum in the US (R01 Clinical Trial Optional) |
93.361 |
RFA-NR-20-002 |
| FY2020 BLM WO Recreation and Visitor Services Funding Opportunity Announcement |
15.225 |
L20AS00069 |
| Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) |
93.121, 93.213, 93.242, 93.273, 93.279, 93.853, 93.865, 93.866, 93.867 |
PAR-20-122 |
| Partnerships for the Development of Universal Influenza Vaccines (R21/R33 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-20-003 |
| National Longitudinal Study of Adolescent to Adult Health (Add Health) Wave 6 (U01 Clinical Trial Not Allowed) |
93.275, 93.307, 93.865, 93.866 |
RFA-AG-21-008 |
| Preventing Adverse Childhood Experiences Data to Action |
93.136 |
CDC-RFA-CE20-2006 |
| National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Disorder (U19 Clinical Trial Optional) |
93.242, 93.273, 93.279 |
PAR-20-119 |
| Multidisciplinary Studies to Improve Understanding of Influenza Transmission (U19 Clinical Trial Optional) |
93.855 |
RFA-AI-20-008 |
| Alzheimers Disease Sequencing Project Functional Genomics Consortium (U01 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-21-006 |
| Limited Competition: Research Centers in Minority Institutions (RCMI) Coordinating Center (U24 Clinical Trial Not Allowed) |
93.307 |
RFA-MD-20-007 |
| National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Disorder (U01 Clinical Trial Optional) |
93.242, 93.273, 93.279 |
PAR-20-118 |
| Three-Dimensional (3D) Human Biomimetics for Infectious Diseases (U19 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-20-009 |
| Assistance to High Energy Cost Communities |
10.859 |
RD-RUS-HECG20 |
| NM Cultural and Paleontological Resource Management |
15.224 |
L20AS00058 |
| FDA's National Curriculum Standard Development and Training Delivery and Development (U18) Clinical Trial Not Allowed |
93.103 |
RFA-FD-20-024 |
| BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-MH-20-128 |
| Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed) |
93.394, 93.395 |
PAR-20-116 |
| Community Facilities Technical Assistance and Training Grant - Disaster Relief Act 2019 Grant Funds |
10.766 |
USDA-RD-CFTAT-2020-DISASTER |
| Planning Projects for Clinical Trials on Effects of Sustained Reductions in Caloric Intake and Related Dietary Practices in Younger and Older Persons (U01 Clinical Trial Optional) |
93.866 |
RFA-AG-21-016 |
| Exploring the Roles of Biomolecular Condensates (BMCs) in HIV replication, latency, or pathogenesis in the context of substance use disorders (R21/R33 Clinical Trial Not Allowed) |
93.279 |
RFA-DA-21-004 |
| Community Facilities Technical Assistance and Training Grant |
10.766 |
USDA-RD-CFTAT-2020 |
| Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-20-019 |
Search Results 4681-4720 of 17927
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 [Next] |
